Formosa Laboratories, Inc. (TPE:4746)
Taiwan · Delayed Price · Currency is TWD 52.00
-0.30 (-0.57%)
Aug 19, 2026, 1:30 PM CST
Formosa Laboratories Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 475.7 | 441.11 | 157.27 | 126.24 | 409.36 | 1,249 |
Depreciation & Amortization | 554.26 | 540.86 | 499.35 | 479.96 | 460.34 | 464.61 |
Other Amortization | 8.23 | 8.23 | 7.58 | 8.37 | 10.58 | 10.39 |
Loss (Gain) From Sale of Assets | -0.18 | -0.09 | 21.61 | -0.09 | -0.05 | -0.11 |
Loss (Gain) From Sale of Investments | 172.02 | 181.82 | 523.05 | 428.92 | -178.78 | -1,296 |
Loss (Gain) on Equity Investments | -4.8 | -8.71 | 2.16 | -5.56 | -7.59 | -9.17 |
Stock-Based Compensation | 0.09 | 0.35 | 36.2 | 2.42 | 2.59 | - |
Provision & Write-off of Bad Debts | -5.16 | -9.06 | 24.14 | -26.46 | 28.35 | -13.87 |
Other Operating Activities | -71.19 | -97.83 | -107.78 | -146.3 | -83.46 | -144.24 |
Change in Accounts Receivable | 50.4 | 113.55 | -260.14 | -121.07 | -69.64 | 2.19 |
Change in Inventory | -287.5 | -4.15 | -114.1 | 4.21 | 37.53 | -188.15 |
Change in Accounts Payable | 42.38 | - | 15.92 | 15.64 | -15.95 | -5.72 |
Change in Unearned Revenue | -17.92 | 60.86 | -133.97 | 93.08 | -36.92 | 67.63 |
Change in Other Net Operating Assets | -94.76 | 88.3 | 55.05 | -33.74 | 86.48 | 172.93 |
Operating Cash Flow | 821.58 | 1,315 | 726.33 | 826.6 | 643.09 | 311.16 |
Operating Cash Flow Growth | -37.13% | 81.08% | -12.13% | 28.54% | 106.68% | -34.49% |
Capital Expenditures | -1,172 | -797.08 | -585.95 | -538.53 | -438.43 | -508.78 |
Sale of Property, Plant & Equipment | 0.18 | 0.91 | 47.44 | 0.09 | 0.05 | 0.31 |
Cash Acquisitions | - | - | -106.78 | - | -29.87 | -71.03 |
Sale (Purchase) of Intangibles | -43.23 | -46.05 | -1.92 | -1.98 | -1.55 | -5.04 |
Investment in Securities | 302.89 | -1.33 | -379.16 | -666.65 | -30.97 | -13 |
Other Investing Activities | -1.19 | -1.75 | 0.71 | -50.36 | -39.95 | 8.05 |
Investing Cash Flow | -913.75 | -845.3 | -1,026 | -1,257 | -540.72 | -589.49 |
Short-Term Debt Issued | - | 430 | - | 50.05 | 432.28 | - |
Long-Term Debt Issued | - | 4,880 | 6,540 | 4,038 | 3,396 | 3,450 |
Total Debt Issued | 6,259 | 5,310 | 6,540 | 4,088 | 3,828 | 3,450 |
Short-Term Debt Repaid | - | -49.98 | -803.57 | -15.67 | -110.03 | -90.64 |
Long-Term Debt Repaid | - | -5,577 | -5,998 | -3,835 | -3,360 | -3,453 |
Total Debt Repaid | -6,156 | -5,627 | -6,801 | -3,851 | -3,470 | -3,543 |
Net Debt Issued (Repaid) | 103.08 | -317.2 | -261.44 | 236.73 | 358.36 | -92.95 |
Common Dividends Paid | -360.77 | -360.77 | -240.51 | -120.26 | -240.51 | - |
Other Financing Activities | - | - | 634.04 | 583.68 | 330.1 | 531.97 |
Financing Cash Flow | -257.69 | -677.96 | 132.09 | 700.14 | 447.95 | 439.02 |
Foreign Exchange Rate Adjustments | 28.81 | -15.69 | 5.77 | -22.77 | -0.38 | -12.16 |
Net Cash Flow | -321.05 | -223.71 | -161.48 | 246.55 | 549.93 | 148.53 |
Free Cash Flow | -350.81 | 518.17 | 140.38 | 288.07 | 204.66 | -197.62 |
Free Cash Flow Growth | - | 269.12% | -51.27% | 40.76% | - | - |
Free Cash Flow Margin | -7.56% | 10.68% | 2.97% | 6.61% | 5.44% | -6.29% |
Free Cash Flow Per Share | -3.08 | 4.27 | 1.16 | 2.39 | 1.69 | -1.63 |
Levered Free Cash Flow | -568.99 | 411.9 | -73.97 | 372.07 | 234.2 | -171.07 |
Unlevered Free Cash Flow | -553.16 | 432.6 | -49.21 | 393.78 | 246.28 | -153.53 |
Cash Interest Paid | 33.16 | 33.16 | 40.49 | 30.8 | 17.73 | 19.79 |
Cash Income Tax Paid | 126.33 | 174.29 | 153.38 | 204.19 | 21.65 | 35.92 |
Change in Working Capital | -307.4 | 258.57 | -437.25 | -40.9 | 1.76 | 50 |